BioCentury
ARTICLE | Clinical News

FCP-3P1: Began a Phase I Canadian trial

January 22, 1996 8:00 AM UTC

Forbes Medi-Tech Inc. (VSE: FMI), Vancouver, B.C. Product: FCP-3P1, tall oil derivative Indication: Lower serum cholesterol Status: Began a Phase I Canadian trial with FCP-3P1, which is derived from t...